» Articles » PMID: 24837162

LC-MS Analysis of Polyclonal IgGs Using IdeS Enzymatic Proteolysis for Oxidation Monitoring

Overview
Publisher Elsevier
Date 2014 May 20
PMID 24837162
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Susceptibility of IgGs to oxidation is a significant issue for intravenous immunoglobulin preparations (IVIG) in liquid solution and raises both safety and efficacy concerns. Here we present an optimized chromatography method coupled to mass spectrometry (MS) to determine the oxidation of Fc/2 fragments derived from polyclonal IgGs after IdeS treatment. Separation of the four IgG subclasses was achieved using a diphenyl column and UV/MS detections were used for quantification and characterization. Several oxidized Fc/2 fragments generated by stress conditions were resolved and oxidized methionines were identified. This procedure can be used to monitor the oxidative status of IVIG preparations during formulation or stability studies.

Citing Articles

Evaluation of Two Chemoenzymatic Glycan Remodeling Approaches to Generate Site-Specific Antibody-Drug Conjugates.

Yang Q, Chen H, Ou C, Zheng Z, Zhang X, Liu Y Antibodies (Basel). 2023; 12(4).

PMID: 37987249 PMC: 10660516. DOI: 10.3390/antib12040071.


Towards middle-up analysis of polyclonal antibodies: subclass-specific N-glycosylation profiling of murine immunoglobulin G (IgG) by means of HPLC-MS.

Blochl C, Regl C, Huber C, Winter P, Weiss R, Wohlschlager T Sci Rep. 2020; 10(1):18080.

PMID: 33093535 PMC: 7581757. DOI: 10.1038/s41598-020-75045-1.


On enzymatic remodeling of IgG glycosylation; unique tools with broad applications.

Sjogren J, Lood R, Nageli A Glycobiology. 2019; 30(4):254-267.

PMID: 31616919 PMC: 7109354. DOI: 10.1093/glycob/cwz085.


Monitoring of immunoglobulin N- and O-glycosylation in health and disease.

de Haan N, Falck D, Wuhrer M Glycobiology. 2019; 30(4):226-240.

PMID: 31281930 PMC: 7225405. DOI: 10.1093/glycob/cwz048.


Differentiating the Effects of Oxidative Stress Tests on Biopharmaceuticals.

Heinzl G, Lai L, Rao V Pharm Res. 2019; 36(7):103.

PMID: 31101998 DOI: 10.1007/s11095-019-2627-2.